Detailed answers about GLYMAB THERAPEUTICS LIMITED, including incorporation, status, business activity, and accounts information.
When was GLYMAB THERAPEUTICS LIMITED founded?
GLYMAB THERAPEUTICS LIMITED was officially incorporated on 24 June 2025 and is registered under company number 16538942. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is GLYMAB THERAPEUTICS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of GLYMAB THERAPEUTICS LIMITED?
GLYMAB THERAPEUTICS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does GLYMAB THERAPEUTICS LIMITED do?
GLYMAB THERAPEUTICS LIMITED operates in the following sector: 72110 - Research and experimental development on biotechnology. This provides insight into the company's primary business activity and industry focus.
What is GLYMAB THERAPEUTICS LIMITED's registered address?
The registered office address of GLYMAB THERAPEUTICS LIMITED is THE BELLHOUSE BUILDING SANDERS ROAD, OXFORD SCIENCE PARK, OXFORD, UNITED KINGDOM, OX4 4GD. This is the official address filed with Companies House for legal and statutory correspondence.
Is GLYMAB THERAPEUTICS LIMITED financially stable?
Financial accounts for GLYMAB THERAPEUTICS LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.